Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344757 · ClinicalTrials.gov registry record · NA
Health Gatherings - For Your Health After Cancer
A NA study of Urogenital Neoplasms and Prostate Neoplasm, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 2
- Study locations
NCT03344757 is a NA study of Urogenital Neoplasms and Prostate Neoplasm that has completed, run by University of Miami. The registered enrollment target is 188 participants, below the 285-participant average among 11 other Urogenital Neoplasms trials with a reported enrollment target (34% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03344757, a NA study of Urogenital Neoplasms and Prostate Neoplasm, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to look at the effects of a 10-week stress management in-person group program. The program will study emotions, stress, and stress management techniques (such as relaxation and coping techniques) on quality of life, distress, depression, and physical health in Spanish- speaking, Hispanic/Latino men diagnosed with Prostate Cancer (PC).
Conditions Studied
Interventions
- BEHAVIORAL Cultural CBSM
- BEHAVIORAL Standard CBSM
Study Locations (2)
Florida
- University of Miami - Miami
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03344757
The ClinicalTrials.gov registry entry for NCT03344757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 11 other Urogenital Neoplasms trials with a reported enrollment target (34% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Urogenital Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Cultural CBSM is the first listed.
NCT03344757 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03344757 about?
NCT03344757 is a clinical study titled "Health Gatherings - For Your Health After Cancer". The purpose of this study is to look at the effects of a 10-week stress management in-person group program. The program will study emotions, stress, and stress management techniques (such as relaxation and coping techniques) on quality of life, distress, depression, and physical health in Spanish- s...
What is the current status of trial NCT03344757?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2017-10-05. Estimated completion is 2024-08-01.
What conditions does trial NCT03344757 study?
This clinical trial studies the following conditions: Urogenital Neoplasms, Prostate Neoplasm, Genital Diseases, Male, Prostatic Diseases, Genital Neoplasms, Male.
What interventions are being tested in trial NCT03344757?
The interventions under investigation include: Cultural CBSM (BEHAVIORAL), Standard CBSM (BEHAVIORAL).
Who is sponsoring clinical trial NCT03344757?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344757 being conducted?
This trial has 2 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urogenital Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
COMPLETED · NA
-
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
RECRUITING · Phase 1
-
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RECRUITING
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
RECRUITING · Phase 1
-
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.